Trial intelligence / Profile preview

Terlipressin in Cirrhosis and Ascites

NCT00115947Phase 3Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Dec 2004
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Cirrhosis and ascites comparing Terlipressin Sequence with Placebo Sequence (2 arms). Primary endpoint: Glomerular Filtration Rate. Started Dec 2004; status: completed.

02

Drugs

terlipressin
03

Conditions

Cirrhosisascites

Beyond the preview

Go deeper on NCT00115947.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00115947.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call